Building upon our understanding of bioenergetics, we now delve into Glycolysis, also known as the Embden-Meyerhof Pathway (EMP). This fundamental metabolic pathway is the initial step in breaking down glucose to generate energy in nearly all living organisms.
Glycolysis (from Greek "glykys" = sweet, "lysis" = splitting) is the process where one molecule of glucose (a 6-carbon sugar) is broken down into two molecules of pyruvate (a 3-carbon compound). This process releases a small amount of energy, which is captured as ATP and NADH.
Glycolysis is an energy-releasing (exergonic) pathway.
Overall Chemical Transformation:
This reaction generates energy that is used to produce ATP:
Free Energy Changes (Standard Biological Conditions, ΔG°'):
ΔG°' = -146 kJ/mol2 × (30.5 kJ/mol) = 61 kJ/molΔG°' (overall) = -146 kJ/mol + 61 kJ/mol = -85 kJ/molThermodynamic Summary:
The significantly negative overall ΔG°' indicates that glycolysis is an exergonic reaction that proceeds spontaneously and is largely irreversible under standard conditions.
Glycolysis releases only a small fraction of the total potential energy stored in glucose. Specifically:
"5.2% of the total free energy that can be released by glucose is released in glycolysis."
The complete oxidation of glucose yields much more energy (ΔG°' = -2840 kJ/mol), meaning the majority of glucose's energy remains in pyruvate and NADH, awaiting further aerobic processing.
Once glucose enters a cell, it has 4 primary metabolic fates, depending on the organism's immediate needs:
The elucidation of glycolysis was a monumental achievement, marking it as one of the first and "oldest" metabolic pathways to be fully understood.
Before carbohydrates can be used by the body, complex forms (polysaccharides and disaccharides) must be broken down into monosaccharides for absorption. This process begins in the mouth and continues in the small intestine.
Digestion involves the enzymatic hydrolysis of glycosidic bonds.
The end products are almost exclusively monosaccharides: glucose, fructose, and galactose.
Monosaccharides are absorbed by intestinal epithelial cells (enterocytes) and then transported into the bloodstream.
Once absorbed, these monosaccharides enter the hepatic portal vein, which carries them directly to the liver. The liver is the primary site for fructose and galactose metabolism, converting them into glucose or its intermediates.
After absorption, our monosaccharides (primarily glucose) enter the bloodstream. The body then has several crucial "fates" or pathways for this glucose, depending on energy needs and hormonal signals.
Imagine glucose as a central hub. From this hub, it can be directed down different "roads":
Glycolysis proceeds through a sequence of ten enzyme-catalyzed reactions, typically divided into two main stages:
This initial stage is a preparatory phase where the glucose molecule is modified and split. It requires an input of energy.
Energy Cost: This stage involves an investment of two molecules of ATP. These ATP molecules are consumed to add the phosphate groups, effectively "priming" the molecule for later energy extraction.
In this stage, the two glyceraldehyde-3-phosphate molecules are converted into pyruvate, generating ATP and NADH.
Energy Gain: This stage produces a total of four molecules of ATP and two molecules of NADH (nicotinamide adenine dinucleotide, an electron carrier) per glucose molecule.
Considering both stages, the overall net gain from glycolysis per molecule of glucose is:
The fact that many intermediates in glycolysis are phosphorylated serves several critical purposes:
Click Here To play the Game of Glycolysis
The first step in glycolysis is a crucial preparatory reaction, where glucose is activated and trapped within the cell.
Glucose is phosphorylated on its carbon 6 (C6) hydroxyl group to form Glucose 6-phosphate (G6P). This reaction consumes one molecule of ATP.
Mg²⁺ as a cofactor.
Following the phosphorylation of glucose, the next step involves a rearrangement of the molecule from an aldose to a ketose.
Glucose 6-phosphate (an aldose) is isomerized (rearranged) into Fructose 6-phosphate (a ketose). This reaction is reversible.
Mg²⁺ as a cofactor.
This isomerization is crucial because it sets up the molecule for the next two steps in glycolysis:
This is a critical and highly regulated step in glycolysis, often considered the "committed step" of the pathway.
Fructose 6-phosphate undergoes a second phosphorylation, this time at its carbon 1 (C1) hydroxyl group, to form Fructose 1,6-bisphosphate. This reaction consumes another molecule of ATP.
Mg²⁺ as a cofactor.
PFK-1 is a key control point because its activity dictates the overall rate of glycolysis. It is allosterically regulated:
After two phosphorylation steps and an isomerization, the 6-carbon sugar is now ready to be split into two 3-carbon molecules, marking the true "lysis" of glycolysis.
Fructose 1,6-bisphosphate (a 6-carbon sugar) is cleaved into two distinct 3-carbon phosphorylated sugars:
This step is crucial because it takes the single 6-carbon sugar and converts it into two 3-carbon molecules. These two molecules will then proceed through the second, "energy payoff" stage. The previous isomerization to fructose 6-phosphate (Step 2) was essential to enable this symmetrical cleavage into two triose phosphates, making the rest of the pathway more efficient.
Following the cleavage of Fructose 1,6-bisphosphate (Step 4), two different 3-carbon sugars are produced: Dihydroxyacetone phosphate (DHAP) and Glyceraldehyde 3-phosphate (GAP). However, only GAP can directly proceed into the next steps of glycolysis. This step ensures that both molecules can be utilized.
Dihydroxyacetone phosphate (DHAP), a ketose, is reversibly isomerized into Glyceraldehyde 3-phosphate (GAP), an aldose.
This isomerization is crucial because:
This concludes the Energy Investment Phase (Reactions 1-5). We have now invested 2 ATP and converted one 6-carbon glucose into two 3-carbon Glyceraldehyde 3-phosphate molecules. The pathway is now ready to enter the Energy Payoff Phase.
We're now entering the Energy Payoff Phase of glycolysis! This is where the cell starts to recover its ATP investment and generate reducing power. Step 6 is the first reaction in this phase, and it's a crucial one as it involves both an oxidation event and the formation of a high-energy phosphate compound.
Each molecule of Glyceraldehyde 3-phosphate (GAP) undergoes a two-part transformation:
This step marks the first direct production of ATP in glycolysis, utilizing the high-energy phosphate bond generated in the previous step.
The high-energy phosphate group from the C1 position of 1,3-Bisphosphoglycerate (1,3-BPG) is transferred to ADP, forming ATP. The remaining molecule is 3-Phosphoglycerate.
Mg²⁺ as a cofactor.
After the first ATP-generating step, the molecule undergoes a structural rearrangement of its phosphate group to prepare for the next high-energy bond formation.
The phosphate group on 3-Phosphoglycerate moves from the carbon at position 3 to the carbon at position 2, forming 2-Phosphoglycerate. This is an intramolecular rearrangement.
Mg²⁺ as a cofactor.
This rearrangement is crucial for the subsequent steps:
Following the migration of the phosphate group, the molecule undergoes a dehydration reaction, which significantly raises the phosphoryl transfer potential of the phosphate group.
A molecule of water (H₂O) is removed from 2-Phosphoglycerate. This dehydration reaction creates a double bond within the molecule and forms the high-energy compound Phosphoenolpyruvate (PEP), which contains an "enol phosphate" bond.
Enolase is inhibited by fluoride ions. This property is exploited in clinical settings: when blood samples are collected for glucose measurement, fluoride is often added to the collection tube to prevent glycolysis by red blood cells, ensuring the measured glucose concentration is accurate.
This is the second and final ATP-generating step in glycolysis, again utilizing substrate-level phosphorylation to produce ATP and the ultimate end-product, pyruvate.
The high-energy phosphate group from Phosphoenolpyruvate (PEP) is transferred to ADP, yielding another molecule of ATP. The product remaining is Pyruvate. The initial enol form of pyruvate immediately tautomerizes to the more stable keto form.
Mg²⁺ and K⁺ as cofactors.
Pyruvate kinase is tightly regulated to control the flow of carbon through glycolysis:
Glycolysis has now broken down one 6-carbon glucose molecule into two 3-carbon pyruvate molecules, produced a net of 2 ATP molecules, and generated 2 NADH molecules for further energy production.
This 2 net ATP and 2 NADH are the immediate energy harvest from glycolysis. The fate of pyruvate and NADH depends on the presence of oxygen.
| Step # | Enzyme Name | Reaction Catalyzed | Key Characteristics / Regulation |
|---|---|---|---|
| 1 | Hexokinase (I, II, III) | Glucose → G6P | Found in most tissues; High affinity for glucose; Inhibited by its product, G6P (feedback inhibition). Traps glucose in the cell. |
| 1 | Glucokinase (IV) | Glucose → G6P | Liver & pancreas; Low affinity (glucose sensor); Not inhibited by G6P; Induced by insulin. Important for glycogen/fat synthesis. |
| 3 | Phosphofructokinase-1 (PFK-1) | F6P → F1,6BP | RATE-LIMITING STEP. Activated by: High AMP, Fructose-2,6-bisphosphate. Inhibited by: High ATP, Citrate. |
| 10 | Pyruvate Kinase | PEP → Pyruvate | Activated by: Fructose-1,6-bisphosphate (feed-forward). Inhibited by: High ATP, Acetyl-CoA, fatty acids. Deficiency can cause hemolytic anemia. |
Isoenzymes (or isozymes) are different forms of an enzyme that catalyze the same reaction but are encoded by different genes, allowing for fine-tuning of metabolic control in different organs.
The primary challenge after glycolysis is to regenerate NAD⁺ from NADH. If NAD⁺ is not regenerated, glycolysis will stop.
When oxygen is scarce (e.g., in vigorously contracting muscles or red blood cells), cells convert pyruvate to lactate to regenerate NAD⁺.
Pyruvate + NADH + H⁺ → Lactate + NAD⁺
When oxygen is abundant, pyruvate and NADH are further oxidized in the mitochondria to generate much more ATP.
The body doesn't just run metabolic pathways at full throttle. A sophisticated system of regulation ensures that glucose is utilized efficiently and ATP is produced only when needed. Glycolysis is primarily regulated at three irreversible steps, each catalyzed by a key enzyme:
These enzymes act as "gatekeepers" that can be turned up or down through two main mechanisms:
Allosteric regulation involves molecules binding to an enzyme at a site other than the active site, causing a conformational change that either increases (activator) or decreases (inhibitor) its activity. This provides rapid feedback based on the cell's immediate energy status.
Inhibited by:
(Rate-Limiting Step)
Activated by:
Inhibited by:
Activated by:
Inhibited by:
Hormones, primarily insulin and glucagon, regulate glycolysis (especially in the liver) to maintain whole-body blood glucose homeostasis. They achieve this mainly by changing the amount or activity of key enzymes.
Promotes Glycolysis:
Inhibits Glycolysis (in the Liver):
The rates of synthesis of glycolytic enzymes can also be regulated at the level of gene transcription. For instance, in conditions of chronic high glucose or in some cancers, the expression of glycolytic enzymes can be upregulated.
Understanding glycolysis is not just an academic exercise; it's essential for comprehending the pathophysiology of numerous diseases and for developing therapeutic strategies.
Many cancer cells exhibit significantly increased rates of glycolysis, even with sufficient oxygen ("Warburg Effect").
Why? While less efficient, rapid glycolysis provides ATP and metabolic intermediates needed for fast proliferation. In low-oxygen tumors, HIF-1 boosts glycolytic enzymes.
Clinical Application: PET Scans use a radioactive glucose analog (FDG) that is avidly taken up by cancer cells, making them "light up" on the scan to locate tumors.
Mature red blood cells (RBCs) lack mitochondria and are entirely dependent on anaerobic glycolysis for ATP.
ATP in RBCs is used to:
A side-product, 2,3-BPG, is crucial as it binds to hemoglobin and facilitates oxygen release to tissues.
A genetic defect in the pyruvate kinase enzyme, primarily affecting RBCs.
Consequences: Insufficient ATP production in RBCs leads to failure of ion pumps, cell swelling, and premature destruction (hemolysis).
Clinical Presentation: Chronic hemolytic anemia, characterized by fatigue, jaundice, and an enlarged spleen.
A metabolic condition with an accumulation of lactate in the blood, leading to a decrease in blood pH.
Causes:
It is a serious condition that can lead to organ dysfunction.
While not a direct defect in glycolysis, its regulation is profoundly affected in diabetes.
Test your knowledge with these 40 questions.
Question 1/40
Here are your results, .
Your Score
38/40
95%